Clinical Evaluation of Tumour Marker Combinations in the Differential Diagnosis of Benign and Malignant Liver Disease

CEA, CA19-9 and CA50 are tumour associated antigens defined by monoclonal antibodies which have been raised against adenocarcinoma cell lines. The aim of this study was to determine whether their combined use could improve diagnostic accuracy in patients with primary and secondary liver tumours. An...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lucarotti, M. E., Rothnie, N. D., Kelly, S. B., Hershman, M. J., Johanssen, C., Nilsson, O., Lindholm, L., Wood, C. B., Williamson, R. C. N., Habib, N. A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 1991
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2442938/
https://ncbi.nlm.nih.gov/pubmed/1777407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/1991/23874
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak